- Report
- October 2026
- 368 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 265 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 168 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 190 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 282 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 130 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 279 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 254 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 381 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 270 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 351 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 462 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 377 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 296 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 277 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 378 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 469 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 561 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- September 2026
- 189 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- September 2026
- 181 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more